首页> 外文期刊>The Analyst: The Analytical Journal of the Royal Society of Chemistry: A Monthly International Publication Dealing with All Branches of Analytical Chemistry >Infrared imaging in breast cancer: automated tissue component recognition and spectral characterization of breast cancer cells as well as the tumor microenvironment
【24h】

Infrared imaging in breast cancer: automated tissue component recognition and spectral characterization of breast cancer cells as well as the tumor microenvironment

机译:乳腺癌的红外成像:乳腺癌细胞以及肿瘤微环境的自动组织成分识别和光谱表征

获取原文
获取原文并翻译 | 示例
           

摘要

Current evaluation of histological sections of breast cancer samples remains unsatisfactory. The search for new predictive and prognostic factors is ongoing. Infrared spectroscopy and its potential to probe tissues and cells at the molecular level without requirement for contrast agents could be an attractive tool for clinical and diagnostic analysis of breast cancer. In this study, we report the successful application of FTIR (Fourier transform infrared) imaging for breast tissue component characterization. We show that specific FTIR spectral signatures can be assigned to the major tissue components of breast tumor samples. We demonstrate that a tissue component classifier can be built based on a spectral database of well-annotated tissues and successfully validated on independent breast samples. We also demonstrate that spectral features can reveal subtle differences within a tissue component, capturing for instance lymphocytic and stromal activation. By investigating in parallel lymph nodes, tonsils and wound healing tissues, we prove the uniqueness of the signature of both lymphocytic infiltrate and tumor microenvironment in the breast disease context. Finally, we demonstrate that the biochemical information reflected in the epithelial spectra might be clinically relevant for the grading purpose, suggesting potential to improve breast cancer management in the future.
机译:当前对乳腺癌样品的组织学切片的评估仍然不能令人满意。正在寻找新的预测和预后因素。红外光谱及其在分子水平上无需造影剂即可探测组织和细胞的潜力,可能是乳腺癌临床和诊断分析的一种有吸引力的工具。在这项研究中,我们报告了FTIR(傅立叶变换红外)成像技术在乳腺组织成分表征中的成功应用。我们表明,特定的FTIR光谱特征可以分配给乳腺肿瘤样品的主要组织成分。我们证明组织成分分类器可以建立在良好注释的组织的光谱数据库的基础上,并在独立的乳腺样本上成功验证。我们还证明了光谱特征可以揭示组织成分内的细微差异,例如捕获淋巴细胞和基质激活。通过研究平行的淋巴结,扁桃体和伤口愈合组织,我们证明了乳腺疾病背景下淋巴细胞浸润和肿瘤微环境的标志性的独特性。最后,我们证明了上皮光谱中反映的生化信息可能与临床相关,可用于分级,这表明将来有可能改善乳腺癌的管理。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号